ASH 2023: MRD Highlights in BioPharma Drug Development

Read More

Longitudinal immunosequencing in healthy people reveals persistent T cell receptors rich in public receptors

Chu et al.
bioRxiv
Papers
February 2018
Authors and Affiliates
Nathaniel D. Chu1,2,3, Haixin Sarah Bi1,3,4, Ryan O. Emerson5, Anna M. Sherwood5, Michael E. Birnbaum1, Harlan S. Robins5,6, Eric J. Alm1,3,7 1Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA. 2Microbiology Graduate Program, Massachusetts Institute of Technology, Cambridge, MA. 3Center for Microbiome Informatics and Therapeutics, Massachusetts Institute of Technology, Cambridge, MA. 4Computational and Systems Biology Program, Massachusetts Institute of Technology, Cambridge, MA. 5Adaptive Biotechnologies, Seattle, WA. 6Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America 7Broad Institute, Cambridge, MA.